Amjevita (adalimumab-atto) / Amgen, Daiichi Sankyo 
Welcome,         Profile    Billing    Logout  
 11 Diseases   10 Trials   10 Trials   362 News 
16 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Amjevita (adalimumab-atto) / Amgen, Daiichi Sankyo
2017-001970-41: Dose reduction and withdrawal of biological therapy in patients with rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis: Protocol for a 18 months multi-centre trial

Ongoing
4
180
Europe
Abatacept, Adalimumab, Certolizumab pegol, Etanercept, Golimumab, Infliximab, Tocilizumab, L04AA24, L04AB04, L04AB05, L04AB01, L04AB06, L04AB02, L04AC07, Concentrate for solution for injection, Concentrate and solvent for solution for infusion, Concentrate and solvent for solution for injection, Concentrate and solvent for suspension for injection, Orencia, Humira, Cimzia, Enbrel, Benepali, Simponi, Remsima, Remicade, RoActemra, Inflectra, Imraldi, Amgevita
MD, PhD Salome Kristensen, The Danish Regions (Regionernes Medicinpulje), The Department of Rheumatology at Aalborg University Hospital, Health Science Research Fund of the Region of Northern Jutland
Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis, Rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis (arthritis of the spine), Diseases [C] - Musculoskeletal Diseases [C05]
 
 
2019-001793-28: Adalimumab dose reduction aiming low drug levels with control of disease activity (ADDORA-LOW)

Ongoing
4
89
Europe
Adalimumab, D2E7, Injection, Humira, Hulio, Amgevita, Hyrimoz, Idacio, Imraldi
Reade, ZonMw
Rheumatoid arthritis, Rheumatoid arthritis, Diseases [C] - Immune System Diseases [C20]
 
 
2020-004391-18: IMPACT OF ANTI-TNF, VEDOLIZUMAB AND TOFACITINIB ON AORTIC STIFFNESS, CAROTID INTIMA-MEDIA THICKNESS AND CARDIOVASCULAR RISK OF PATIENTS WITH ULCERATIVE COLITIS Impact des anti-TNF, du vedolizumab et du tofacitinib sur la rigidité aortique, l'épaisseur de l'intima-média carotidienne et le risque cardiovasculaire des patients atteints de rectocolite hémorragique

Not yet recruiting
4
100
Europe
Inflectra 100 mg, AMGEVITA, Simponi, Entyvio 300 mg, XELJANZ, Powder and solvent for concentrate for solution for infusion, Solution and suspension for suspension for injection in pre-filled syringe, Solution for injection in pre-filled pen, Tablet, Inflectra 100 mg, AMGEVITA, Simponi, Entyvio 300 mg, XELJANZ
CHU Amiens-Picardie, Pfizer
ulcerative colitis rectocolite hémorragique, ulcerative colitis rectocolite hémorragique, Diseases [C] - Digestive System Diseases [C06]
 
 
2020-003420-16: A study comparing two different therapeutic approaches in the treatment of moderate to severe ulcerative colitis. Comparación prospectiva de dos estrategias de tratamiento para la colitis ulcerosa de inicio temprano: top-down frente a step-up

Ongoing
4
350
Europe
Adalimumab, Azatioprina, Prednisone, [n.d.], Solution for injection in pre-filled syringe, Amgevita
Instituto Clinico Humanitas, IRCCS ISTITUTO CLINICO HUMANITAS, Amgen, Amgen S.r.l.
Moderate to severe ulcerative colitis Colitis ulcerosa de moderada a severa, Ulcerative colitis in a moderate or severe form Colitis ulcerosa en forma moderada o severa., Diseases [C] - Digestive System Diseases [C06]
 
 
2019-003662-40: Prospective, open-label, single-arm, single-center phase IV clinical trial to evaluate efficacy and safety of the adalimumab biosimilar Amgevita in subjects with moderate to severe active chronic inflammatory bowel diesease (Crohn's disease and ulcerative colitis)

Not yet recruiting
4
82
Europe
Solution for injection in pre-filled syringe, Solution for injection in pre-filled pen, Amgevita 40 mg Injektionslösung in einer Fertigspritze, Amgevita 40 mg Injektionslösung im Fertigpen
Universitätsklinikum Erlangen, Amgen GmbH
Moderate to severe active chronic inflammatory bowel disease Mittelschwere bis schwere aktive chronisch entzündliche Darmerkrankung, Diseases [C] - Digestive System Diseases [C06]
 
 
FREE, NCT04646187 / 2020-001811-26: De-escalation of Anti-TNF Therapy in Inflammatory Bowel Disease

Enrolling by invitation
4
148
Europe
Infliximab, Remicade, Flixabi, Inflectra, Remsima, Zessly, Adalimumab, Humira, AMGEVITA, Hulio, Hyrimoz, Idacio, Imraldi
University Medical Center Groningen, European Crohn´s and Colitis Organisation, Bühlmann Laboratories AG
Inflammatory Bowel Diseases, Crohn Disease, Colitis, Ulcerative
03/26
03/26
2021-005287-21: Physiological effects of high intensity exercise training in rheumatoid arthritis patients in biologic anti-inflammatory treatment; A randomized controlled study Fysiologiske effekter af højintens træning hos leddegigt-patienter i biologisk behandling: et randomiseret kontrolleret studie.

Not yet recruiting
4
80
Europe
Injection, Kevzara, AMGEVITA
Rigshospitalet, Center for Aktiv Sundhed, section 7641, Gangstedfonden, Novo Nordisk Fonden, Region Hovedstadens Forskningsfond, Trygfonden, Kong Christian den Tiendes Fond
Rheumatoid Athritis, Rheumatoid Arthritis is a chronic autoimmune disease in which the body attacks its own healthy tissue, primarily the joints., Diseases [C] - Immune System Diseases [C20]
 
 
CAMEO, NCT05781152: Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease

Recruiting
4
900
Canada, US
Anti-TNF therapy, Remicade, Inflectra, Renflexis, Avsola, Humira, Amgevita, Hulio, Hadlima, Hyrimoz, Idacio
Connecticut Children's Medical Center, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Emory University, Children's Hospital Medical Center, Cincinnati, University of North Carolina, Chapel Hill
Crohn Disease
07/28
07/29
2021-000542-18: A Study to Investigate the Impact of Switching Between ABP 501 and Adalimumab for the Treatment of Subjects with Moderate to Severe Plaque Psoriasis

Not yet recruiting
3
414
Europe
ABP 501-HCF, Solution for injection in pre-filled syringe, Humira
Amgen Inc., Amgen Inc.
Moderate to Severe Plaque Psoriasis, Moderate to Severe Plaque Psoriasis, Diseases [C] - Immune System Diseases [C20]
 
 
NCT04610476: Impact of Tapering Immunosuppressants on Maintaining Minimal Disease Activity in Adult Subjects With Psoriatic Arthritis

Recruiting
3
270
Europe
Prednisolone, Prednisolone generic drugs, Sulfasalazine, Azulfidine, Leflunomide, Arava, Methotrexate, Lantarel, Metex, Tofacitinib, Xeljanz, Apremilast, Otezla, Etanercept, Enbrel, Erelzi, Benepali, Adalimumab, Humira, Amgevita, Imraldi, Hyrimoz, Infliximab, Remicade, Zessly, Inflectra, Certolizumab pegol, Cimzia, Golimumab, Simponi, Abatacept, Orencia, Secukinumab, Cosentyx, Ixekizumab, Taltz, Ustekinumab, Stelara
University of Erlangen-Nürnberg Medical School
Psoriatic Arthritis, Withdrawal, Reduction
10/24
10/25
NCT05995691: Study to Determine the Pharmacokinetic (PK) Bioequivalence of ABP 501 and Adalimumab (Humira®) in Healthy Adult Japanese Participants

Completed
1
179
NA
ABP 501, Adalimumab, Humira®
Amgen
Healthy Volunteers
12/15
12/15
NCT05909852: A Study Comparing the Pharmacokinetics (PK) of ABP 501 40 mg/0.4 mL (ABP 501-HCF) and ABP 501 40 mg/0.8 ml (ABP 501-LCF) in Healthy Adult Participants

Completed
1
372
US
ABP 501-HCF, ABP 501-LCF
Amgen
Adalimumab
11/21
11/21
Rhoneswitch, NCT04422171: A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar

Recruiting
N/A
400
Europe
University Hospital, Grenoble
IBD Patients, Originator Treatment, Biosimilar, Switch Back
06/21
01/23
REALISE, NCT05090124: Experimental Medicine Studies of the Brain in Patients With Rheumatoid Arthritis

Completed
N/A
46
Europe
Adalimumab, Humira, Amgevita, Imraldi, Hyrimoz, Hulio, Placebo, Sodium chloride 0.9% for injection
NHS Greater Glasgow and Clyde, University of Glasgow
Rheumatoid Arthritis
11/24
11/24
NeuMRA, NCT04378621: Effect of Antiinflammatory Treatment Versus Hand Training on Neuropsychiatric Comorbidity in RA-patients

Active, not recruiting
N/A
212
Europe
TNF-α inhibitor OR JAK inhibitor, TNF-a inhibitors: Etanercept (Enbrel, Benapali), Infliximab (Remicade, Inflectra, Flixabi), Adalimumab (Humira, Imraldi, AMGEVITA), Certolizumabpegol (Cimzia), Golimumab (Simponi), JAK-inhibitors: Baricitinib (Olumiant), Tofacitinib (Xeljanz), Hand training, physiotherapy of hands
Vastra Gotaland Region
Rheumatoid Arthritis, Pain, Fatigue, Cognitive Decline, Depression, Brain Diseases, Hand Rheumatism
09/25
09/25
NCT05379049: Therapeutic Response to Tumor Necrosis Factor-alpha (TNF-alpha) Antagonists in Rheumatoid Arthritis.

Recruiting
N/A
80
RoW
Infliximab: Adalimumab; Etanercept;, Remicade, Remsima، Humira, amgevita، Enbrel
University of Sulaimani
Rheumatoid Arthritis, Inflammatory Arthritis, Ankylosing Spondylitis
08/22
10/22

Download Options